CoChat

Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study

Fernandes, Victor Augusto Ramos, dos Santos, Gabriela Pereira, Iatecola, Amilton, Buchaim, Daniela Vieira, Garcia, Ionaly Judith Faria, Reis, Carlos Henrique Bertoni, Bueno, Lívia Maluf Menegazzo, Pagani, Bruna Trazzi, Buchaim, Rogerio Leone, da Cunha, Marcelo Rodrigues · 2025 · Pathophysiology
Cited by 1

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background/Objectives: Duchenne muscular dystrophy (DMD) is a genetic disease characterized by a lack of dystrophin caused by mutations in the DMD gene, and some minor cases are due to decreased levels of dystrophin, leading to muscle weakness and motor impairment. Creatine supplementation has demonstrated several benefits for the muscle, such as increased strength, enhanced tissue repair, and improved ATP resynthesis. This preliminary study aimed to investigate the effects of creatine on the gastrocnemius muscle in dystrophy muscle (MDX) and healthy C57BL/10 mice. Methods: Twenty MDX and C57Bl/10 mice were organized into groups and supplemented or not with creatine in a dosage of 0.3 mg for 8 weeks. Gastrocnemius tissue was analyzed using histomorphology and histomorphometric techniques. Results: The results demonstrated potential anti-inflammatory effects of creatine, with less observation of inflammatory infiltrates, the preservation of intramuscular glycogen, and reduction in tissue fibrosis in supplemented animals. Conclusions: These findings suggest that creatine may enhance tissue function and slow the progression of DMD. However, further research, with more analysis, is needed to elucidate molecular mechanisms underlying creatine’s effects on reducing mononuclear leukocytes and its role in mitigating tissue fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pathophysiology32010002

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 42

  1. 2022, Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids, Bol. Med. Hosp. Infant. Mex., 79, 275
  2. Kariyawasam, 2022, Incidence of Duchenne muscular dystrophy in the modern era; an Australian study, Eur. J. Hum. Genet., 30, 1398, 10.1038/s41431-022-01138-2 · doi:10.1038/s41431-022-01138-2
  3. Salmaninejad, 2021, Common therapeutic advances for Duchenne muscular dystrophy (DMD), Int. J. Neurosci., 131, 370, 10.1080/00207454.2020.1740218 · DOI
  4. Fortunato, 2021, The DMD gene and therapeutic approaches to restore dystrophin, Neuromuscul. Disord., 31, 1013, 10.1016/j.nmd.2021.08.004 · DOI
  5. Juan, 2022, Duchenne Muscular Dystrophy, Orthop. Newborn Young Child. Pract. Clin. Guid., 7, 363
  6. Birnkrant, 2018, Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management, Lancet Neurol., 17, 251, 10.1016/S1474-4422(18)30024-3 · DOI · Paper page
  7. Timpani, C.A., Goodman, C.A., Stathis, C.G., White, J.D., Mamchaoui, K., Butler-Browne, G., Gueven, N., Hayes, A., and Rybalka, E. (2020). Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy. Sci. Rep., 10. · DOI
  8. Forbes, S.C., Cordingley, D.M., Cornish, S.M., Gualano, B., Roschel, H., Ostojic, S.M., Rawson, E.S., Roy, B.D., Prokopidis, K., and Giannos, P. (2022). Effects of Creatine Supplementation on Brain Function and Health. Nutrients, 14. · DOI · Paper page
  9. Farshidfar, 2017, Creatine Supplementation and Skeletal Muscle Metabolism for Building Muscle Mass- Review of the Potential Mechanisms of Action, Curr. Protein Pept. Sci., 18, 1273, 10.2174/1389203718666170606105108 · DOI · Paper page
  10. Delforno, 2022, Renal, hepatic and muscle effects of creatine supplementation in an older adults experimental model, Clin. Nutr. ESPEN, 48, 464, 10.1016/j.clnesp.2021.12.020 · DOI
  11. Dupuy, O., Douzi, W., Theurot, D., Bosquet, L., and Dugué, B. (2018). An evidence-based approach for choosing post-exercise recovery techniques to reduce markers of muscle damage, Soreness, fatigue, and inflammation: A systematic review with meta-analysis. Front. Physiol., 9. · DOI · Paper page
  12. Fernandes, 2023, Use of Creatine Monohydrate in MDX Mice: Morphometric and Stereological Analysis of the Diaphragm, Med. Mod., 30, 191, 10.31689/rmm.2023.30.3.191 · DOI
  13. Wallimann, T., Hall, C.H.T., Colgan, S.P., and Glover, L.E. (2021). Creatine Supplementation for Patients with Inflammatory Bowel Diseases: A Scientific Rationale for a Clinical Trial. Nutrients, 13. · DOI · Paper page
  14. Larcher, T., Lafoux, A., Tesson, L., Remy, S.V., Thepenier, V., François, V., Le Guiner, C., Goubin, H., Dutilleul, M.V., and Guigand, L. (2014). Characterization of dystrophin deficient rats: A new model for duchenne muscular dystrophy. PLoS ONE, 9. · DOI · Paper page
  15. Arruda, 2023, Histological Effects of Creatine Monohydrate Supplementation on Muscle Tissue in Wistar Rats, Med. Mod., 30, 111, 10.31689/rmm.2023.30.2.111 · DOI
  16. Banov, 2022, Efeitos da suplementação de creatina sobre o tecido muscular de idosos: Revisão sistemática de literatura, Rev. Multidiscip. Saúde, 4, 38
  17. Young, 2007, The effect of creatine supplementation on mass and performance of rat skeletal muscle, Life Sci., 81, 710, 10.1016/j.lfs.2007.06.029 · DOI
  18. Edouard, 2023, Traumatic muscle injury, Nat. Rev. Dis. Prim., 9, 56, 10.1038/s41572-023-00469-8 · DOI
  19. Csapo, R., Gumpenberger, M., and Wessner, B. (2020). Skeletal Muscle Extracellular Matrix—What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review. Front. Physiol., 11. · DOI · Paper page
  20. Gesemann, 1996, Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor, Neuron, 16, 755, 10.1016/S0896-6273(00)80096-3 · DOI · Paper page
  21. Gao, 2015, The Dystrophin Complex: Structure, function and implications for therapy, Compr. Physiol., 5, 1223, 10.1002/cphy.c140048 · DOI · Paper page
  22. Lamothe, 2022, CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy, Neurotherapeutics, 19, 931, 10.1007/s13311-022-01197-9 · DOI
  23. Elangkovan, 2021, Gene Therapy for Duchenne Muscular Dystrophy, J. Neuromuscul. Dis., 8, S303, 10.3233/JND-210678 · DOI · Paper page
  24. Roberts, 2023, Therapeutic approaches for Duchenne muscular dystrophy, Nat. Rev. Drug Discov., 22, 917, 10.1038/s41573-023-00775-6 · DOI
  25. Danisovic, L., Culenova, M., and Csobonyeiova, M. (2018). Induced pluripotent stem cells for duchenne muscular dystrophy modeling and therapy. Cells, 7. · DOI
  26. Mukund, 2020, Skeletal muscle: A review of molecular structure and function, in health and disease, Wiley Interdiscip. Rev. Syst. Biol. Med., 12, 1, 10.1002/wsbm.1462 · DOI · Paper page
  27. Bez Batti Angulski, A., Hosny, N., Cohen, H., Martin, A.A., Hahn, D., Bauer, J., and Metzger, J.M. (2023). Duchenne muscular dystrophy: Disease mechanism and therapeutic strategies. Front. Physiol., 14. · DOI · Paper page
  28. Salera, S., Menni, F., Moggio, M., Guez, S., Sciacco, M., and Esposito, S. (2017). Nutritional Challenges in Duchenne Muscular Dystrophy. Nutrients, 9. · DOI
  29. Lorena, 2023, Biomarkers for Duchenne muscular dystrophy progression: Impact of age in the mdx tongue spared muscle, Skelet. Muscle., 13, 16, 10.1186/s13395-023-00325-z · DOI
  30. Febbraio, 1995, Effect of creatine supplementation on intramuscular TCr, metabolism and performance during intermittent, supramaximal exercise in humans, Acta Physiol. Scand., 155, 387, 10.1111/j.1748-1716.1995.tb09988.x · DOI · Paper page
  31. Volek, 2004, Scientific basis and practical aspects of creatine supplementation for athletes, Nutrition., 20, 609, 10.1016/j.nut.2004.04.014 · DOI
  32. Forbes, 2023, Creatine supplementation and endurance performance: Surges and sprints to win the race, J. Int. Soc. Sports Nutr., 20, 2204071, 10.1080/15502783.2023.2204071 · DOI · Paper page
  33. Alghannam, A.F., Gonzalez, J.T., and Betts, J.A. (2018). Restoration of muscle glycogen and functional capacity: Role of post-exercise carbohydrate and protein co-ingestion. Nutrients, 10. · DOI · Paper page
  34. Houang, 2018, Muscle membrane integrity in Duchenne muscular dystrophy: Recent advances in copolymer-based muscle membrane stabilizers, Skelet. Muscle, 8, 31, 10.1186/s13395-018-0177-7 · DOI
  35. Baker, 2010, Interaction among skeletal muscle metabolic energy systems during intense exercise, J. Nutr. Metab., 2010, 905612, 10.1155/2010/905612 · DOI · Paper page
  36. Padilha, 2017, Oral creatine supplementation attenuates muscle loss caused by limb immobilization: A systematic review, Fisioter. Em Mov., 30, 831, 10.1590/1980-5918.030.004.ar01 · DOI
  37. Aguiar Bonfim Cruz, A.J., Brooks, S.J., Kleinkopf, K., Brush, C.J., Irwin, G.L., Schwartz, M.G., Candow, D.G., and Brown, A.F. (2024). Creatine Improves Total Sleep Duration Following Resistance Training Days versus Non-Resistance Training Days among Naturally Menstruating Females. Nutrients, 16. · DOI
  38. Lis-López, L., Bauset, C., Seco-Cervera, M., and Cosín-Roger, J. (2021). Is the macrophage phenotype determinant for fibrosis development?. Biomedicines, 9. · DOI
  39. Kornegay, 2018, The Paradox of Muscle Hypertrophy in Muscular Dystrophy, Phys. Med. Rehabil. Clin. N. Am., 23, 149, 10.1016/j.pmr.2011.11.014 · DOI
  40. Delaney, 2024, Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models, Exp. Physiol., 109, 1426, 10.1113/EP091967 · DOI
  41. Walters, 2017, Muscle hypertrophy and pseudohypertrophy, Pract. Neurol., 17, 369, 10.1136/practneurol-2017-001695 · DOI
  42. Polak, 2021, The multifaceted view of heart problem in Duchenne muscular dystrophy, Cell. Mol. Life Sci., 78, 5447, 10.1007/s00018-021-03862-2 · DOI

Cited by

See all 1

Metadata

Authors
Fernandes, V. A. R., dos Santos, G. P., Iatecola, A., Buchaim, D. V., Garcia, I. J. F., Reis, C. H. B., Bueno, L. M. M., Pagani, B. T., Buchaim, R. L., & da Cunha, M. R.
Affiliations
  • Postgraduate Program in Health Sciences, Faculty of Medicine of Jundiaí (FMJ), Jundiaí 13202-550, Brazil
  • Neurobiology Study Group, Nossa Senhora do Patrocínio University Center (CEUNSP), Itu 13300-200, Brazil
  • Graduate Program in Anatomy of Domestic and Wild Animals, Faculty of Veterinary Medicine and Animal Science, University of Sao Paulo (FMVZ/USP), Sao Paulo 05508-270, Brazil
  • Medical and Dentistry School, University Center of Adamantina (FAI), Adamantina 17800-000, Brazil
  • Beneficent Hospital (HBU), University of Marilia (UNIMAR), Marilia 17525-160, Brazil
  • Dentistry School, University of Marilia (UNIMAR), Marilia 17525-902, Brazil
Venue
Pathophysiology
Publisher
MDPI AG
Published
2025-01-06
Volume
32
Issue
1
Pages
2
ISSN
1873-149X
Cited by
1
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study. https://app.cochat.ai/papers/10.3390/pathophysiology32010002
The paper
Fernandes, V. A. R., dos Santos, G. P., Iatecola, A., Buchaim, D. V., Garcia, I. J. F., Reis, C. H. B., Bueno, L. M. M., Pagani, B. T., Buchaim, R. L., & da Cunha, M. R. (2025). Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study. Pathophysiology. https://doi.org/10.3390/pathophysiology32010002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.